Research has linked ulcerative colitis (UC) to an increased risk of heart disease, including heart attack and stroke. Some UC treatments may help reduce the risk of heart problems, though more research is necessary. UC refers to chronic inflammation in the inner lining of the large intestine. People with UC may also develop inflammation in...
Tag: <span>ulcerative colitis</span>
Post
Front-line drug for ulcerative colitis found to have additional mechanism of action that until now remained elusive
JULY 23, 2024 by Delthia Ricks , Medical Xpress Response to vedolizumab is associated with loss of lymphoid aggregate size. (A) Representative hematoxylin and eosin staining of colonic biopsies from responder (R) and nonresponder (NR) patients with UC taken before and after VDZ therapy. Lymphoid aggregate (LA) border indicated with red line. Scale bars, 100...
Post
Low Serum Vitamin D Levels Linked to Ulcerative Colitis
Marilynn Larkin October 26, 2023 TOPLINE: Serum vitamin D levels are significantly lower and the prevalence of vitamin D deficiency is significantly higher in patients with ulcerative colitis (UC) compared with controls, although a causal relationship cannot be demonstrated. METHODOLOGY: TAKEAWAY: SOURCE: Yan Wang, PhD, Department of Gastroenterology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an,...
Post
FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis
by The Mount Sinai Hospital Endoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Credit: Samir/Wikipedia The U.S. Food and Drug Administration (FDA) approved mirikizumab, on October 26, 2023, a highly effective new treatment for ulcerative colitis (UC),...
Post
New AGA guideline recommends blood and stool tests for monitoring ulcerative colitis
AMERICAN GASTROENTEROLOGICAL ASSOCIATION Bethesda, MD (Feb. 21, 2023) — In new evidence-based guidelines, the American Gastroenterological Association (AGA) recommends non-invasive biomarkers as a first-line strategy for monitoring many patients with ulcerative colitis (UC). These guidelines were published today in Gastroenterology. The AGA guidelines outline use cases for three biomarkers that provide accurate insights into ulcerative colitis disease...
Post
In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis
by Nanjing University School of Life Sciences Evaluation of the activity of TNF-α siRNA-encapsulating sEVs in an ex vivo model. a Schematic of the experimental design. Acute UC was induced in male BALB/c mice by replacing their drinking water with a 2.5% DSS solution for 7 days. DSS mice were intravenously injected with 5 mg/kg CMV-scrR...
Post
Quicker Remission With Tofacitinib vs Vedolizumab in Ulcerative Colitis: Study
Liam Davenport July 11, 2022 When anti–tumor necrosis factor-alpha (anti-TNF) treatment fails to achieve remission for patients with ulcerative colitis (UC), tofacitinib (Xeljanz) appears more effective sooner than vedolizumab (Entyvio), suggests a Dutch registry study. Data on nearly 150 patients with UC who had already undergone treatment with anti-TNF drugs showed that combined clinical and biochemical remission was about five times more likely...
Post
Hydrogen generated by Si-based agent attenuates inflammation in ulcerative colitis mouse model
by Osaka University Fig. 1. Amount of hydrogen generated per 1 g of the mouse gastrointestinal tract in the control group compared with in the mice given the silicon (Si)-based agent. Credit: Scientific Reports (2022). DOI: 10.1038/s41598-022-13655-7 Many people worldwide suffer from a chronic type of inflammatory bowel disease (IBD) called ulcerative colitis (UC), which is characterized by...
Post
Novel oral nano-in-micro system provides efficient curcumin delivery to alleviate ulcerative colitis
By Dr. Priyom Bose, Ph.D. Jul 5 2022Reviewed by Aimee Molineux Ulcerative colitis (UC) is an inflammatory disease of the distal colon, which affects the gastrointestinal tract. This disease persists for a prolonged period and is often recurring. Patients with UC require long-term treatment to control disease progression. Several types of drugs, such as salicylic...
Post
Steroids Less Effective in Older-Onset Ulcerative Colitis
Heidi Splete May 10, 2022 Intravenous steroids were less effective in ulcerative colitis patients with older-onset disease, compared with younger-onset patients, according to data from nearly 500 individuals. A combination of rising ulcerative colitis rates and an aging population has driven an increase in older-onset UC worldwide, Shinji Okabayashi, MD, of Kyoto University, and colleagues wrote in a study...